Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02880267 · ClinicalTrials.gov registry record · NA
Effectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring System
A NA study, sponsored by DexCom.
- Completed
- Registry status
- NA
- Development phase
- 304
- Enrollment target
NCT02880267 is a NA study that has completed, run by DexCom. The registered enrollment target is 304 participants.
The verdict
NCT02880267, a NA study, has completed, sponsored by DexCom.
- COMPLETED
- Registry status
- NA
- Development phase
- 304 participants
- Enrollment target
Study Summary
Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring (CGM) System
Interventions
- DEVICE CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02880267
The ClinicalTrials.gov registry entry for NCT02880267 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DexCom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CGM is the first listed.
NCT02880267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02880267 about?
NCT02880267 is a clinical study titled "Effectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring System". Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring (CGM) System
What is the current status of trial NCT02880267?
This trial is currently completed. It is a NA study. The enrollment target is 304 participants. The study started on 2016-05. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02880267?
The interventions under investigation include: CGM (DEVICE).
Who is sponsoring clinical trial NCT02880267?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.